cAMP-activated Ca2+ signaling is required for CFTR-mediated serous cell fluid secretion in porcine and human airways

Journal of Clinical Investigation

Volumn 120, Issue 9, 2010, Pages 3137-3148

  Lee, Robert J ^a   Kevin Foskett, J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUMETANIDE; CARBACHOL; CYCLIC AMP; FORSKOLIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; VASOACTIVE INTESTINAL POLYPEPTIDE;

ACINAR CELL; ANIMAL CELL; ARTICLE; BRONCHUS MUCOSA; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL ISOLATION; CHOLINERGIC STIMULATION; CYSTIC FIBROSIS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SECRETION; SUBMUCOSA; SWINE; ADULT; ANIMAL; BODY FLUID; BRONCHIOLE; EPITHELIUM CELL; EXOCRINE GLAND; GENETICS; LUNG; METABOLISM; NEWBORN; PHYSIOLOGY; RESPIRATORY SYSTEM; TRACHEA;

ADULT; ANIMALS; ANIMALS, NEWBORN; BODY FLUIDS; BRONCHIOLES; CALCIUM SIGNALING; CARBACHOL; CYCLIC AMP; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL CELLS; EXOCRINE GLANDS; HUMANS; LUNG; RESPIRATORY SYSTEM; SUS SCROFA; TRACHEA;

EID: 77956375693     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI42992     Document Type: Article

References (45)

1. Ballard ST, Spadafora D. Fluid secretion by submucosal glands of the tracheobronchial airways. Respir Physiol Neurobiol. 2007;159(3):271-277.
2. Engelhardt JF, et al. Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nat Genet. 1992;2(3):240-248.
3. 2+-evoked fluid secretion by murine nasal submucosal gland serous acinar cells. J Physiol. 2007;582(pt 3):1099-1124.
4. 2+-stimulated fluid secretion by porcine bronchial submucosal gland serous acinar cells. Am J Physiol Lung Cell Mol Physiol. 2010;298(2):L210-L231.
5. Joo NS, Irokawa T, Robbins RC, Wine JJ. Hyposecretion, not hyperabsorption, is the basic defect of cystic fibrosis airway glands. J Biol Chem. 2006;281(11):7392-7398.
6. Joo NS, Irokawa T, Wu JV, Robbins RC, Whyte RI, Wine JJ. Absent secretion to vasoactive intestinal peptide in cystic fibrosis airway glands. J Biol Chem. 2002;277(52):50710-50715.
7. Joo NS, Saenz Y, Krouse ME, Wine JJ. Mucus secretion from single submucosal glands of pig. Stimulation by carbachol and vasoactive intestinal peptide. J Biol Chem. 2002;277(31):28167-28175.
8. Ianowski JP, Choi JY, Wine JJ, Hanrahan JW. Mucus secretion by single tracheal submucosal glands from normal and CFTR knock-out mice. J Physiol. 2007;580(pt 1):301-314
9. Wine JJ, Joo NS. Submucosal glands and airway defense. Proc Am Thorac Soc. 2004;1(1):47-53.
10. Dickson L, Finlayson K. VPAC and PAC receptors: From ligands to function. Pharmacol Ther. 2009;121(3):294-316.
11. Wine JJ. Parasympathetic control of airway submucosal glands: central reflexes and the airway intrinsic nervous system. Auton Neurosci. 2007;133(1):35-54.
12. Lazarus SC, Basbaum CB, Barnes PJ, Gold WM. cAMP immunocytochemistry provides evidence for functional VIP receptors in trachea. Am J Physiol. 1986;251(1 pt 1):C115-C119.
13. Peatfield AC, Barnes PJ, Bratcher C, Nadel JA, Davis B. Vasoactive intestinal peptide stimulates tracheal submucosal gland secretion in ferret. Am Rev Respir Dis. 1983;128(1):89-93.
14. Liu YC, Khawaja AM, Rogers DF. Effect of vasoactive intestinal peptide (VIP)-related peptides on cholinergic neurogenic and direct mucus secretion in ferret trachea in vitro. Br J Pharmacol. 1999;128(6):1353-1359.
15. Wagner U, Bredenbroker D, Storm B, Tackenberg B, Fehmann HC, von Wichert P. Effects of VIP and related peptides on airway mucus secretion from isolated rat trachea. Peptides. 1998;19(2):241-245.
16. Salinas D, et al. Submucosal gland dysfunction as a primary defect in cystic fibrosis. FASEB J. 2005;19(3):431-433.
17. 2+-stimulated fluid secretion. J Gen Physiol. 2008;132(1):161-183.
18. Choi JY, et al. Synergistic airway gland mucus secretion in response to vasoactive intestinal peptide and carbachol is lost in cystic fibrosis. J Clin Invest. 2007;117(10):3118-3127.
19. Fatatis A, Holtzclaw LA, Avidor R, Brenneman DE, Russell JT. Vasoactive intestinal peptide increases intracellular calcium in astroglia: synergism with alpha-adrenergic receptors. Proc Natl Acad Sci U S A. 1994;91(6):2036-2040.
20. Schaad NC, Vanecek J, Rodriguez IR, Klein DC, Holtzclaw L, Russell JT. Vasoactive intestinal peptide elevates pinealocyte intracellular calcium concentrations by enhancing influx: evidence for involvement of a cyclic GMP-dependent mechanism. Mol Pharmacol. 1995;47(5):923-933.
21. 2+ by vasoactive intestinal polypeptide in endothelial cells. Eur J Pharmacol. 1997;339(2-3):227-235.
22. i and cyclic AMP in CHO cells expressing Galpha16. Cell Calcium. 2001;30(4):229-234.
23. McCulloch DA, et al. Additional signals from VPAC/PAC family receptors. Biochem Soc Trans. 2002;30(4):441-446.
24. 2+ responses to sub-picomolar and nanomolar PACAP in pancreatic beta-cells are mediated by VPAC2 and PAC1 receptors. Regul Pept. 2004;123(1-3):147-153.
25. 2+ transients via cAMP-dependent mechanism. Am J Physiol Cell Physiol. 2006;291(2):C375-C385.
26. Muanprasat C, Sonawane ND, Salinas D, Taddei A, Galietta LJ, Verkman AS. Discovery of glycine hydrazide pore-occluding CFTR inhibitors: mechanism, structure-activity analysis, and in vivo efficacy. J Gen Physiol. 2004;124(2):125-137.
27. Ma T, et al. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest. 2002;110(11):1651-1658.
28. Rogers CS, et al. Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science. 2008;321(5897):1837-1841.
29. Stoltz DA, et al. Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci Transl Med. 2010;2(29):29ra31.
30. - permeabilities in normal and CFTR-expressing mouse L cells. Biochim Biophys Acta. 1993;1152(1):83-90.
31. Dawson DC, Smith SS, Mansoura MK. CFTR: mechanism of anion conduction. Physiol Rev. 1997;79(1 suppl):S47-S75.
32. Hartzell C, Putzier I, Arreola J. Calcium-activated chloride channels. Annu Rev Physiol. 2005;67:719-758.
33. Raphael GD, Jeney EV, Baraniuk JN, Kim I, Meredith SD, Kaliner MA. Pathophysiology of rhinitis. Lactoferrin and lysozyme in nasal secretions. J Clin Invest. 1989;84(5):1528-1535.
34. Baraniuk JN, Kaliner MA. Neuropeptides and nasal secretion. J Allergy Clin Immunol. 1990;86(4 pt 2):620-627.
35. Baraniuk JN, et al. Vasoactive intestinal peptide in human nasal mucosa. J Clin Invest. 1990;86(3):825-831.
36. Groneberg DA, et al. Distribution of respiratory mucin proteins in human nasal mucosa. Laryngoscope. 2003;113(3):520-524.
37. Song Y, Salinas D, Nielson DW, Verkman AS. Hyperacidity of secreted fluid from submucosal glands in early cystic fibrosis. Am J Physiol Cell Physiol. 2005;290(3):C741-C749.
38. - content controls cell volume in single salivary acinar cells during fluid secretion. Am J Physiol. 1990;259(6 pt 1):C998-C1004.
39. Thiagarajah JR, Song Y, Haggie PM, Verkman AS. A small molecule CFTR inhibitor produces cystic fibrosis-like submucosal gland fluid secretions in normal airways. FASEB J. 2004;18(7):875-877.
40. Choi JY, et al. Substance P stimulates human airway submucosal gland secretion mainly via a CFTR-dependent process. J Clin Invest. 2009;119(5):1189-1200.
41. 2+ release channels. Physiol Rev. 2007;87(2):593-658.
42. i signals in human cystic fibrosis airway epithelia. J Biol Chem. 2005;280(11):10202-10209.
43. i in single cells. Science. 1989;244(4912):1582-1585.
44. Melvin JE, Yule D, Shuttleworth T, Begenisich T. Regulation of fluid and electrolyte secretion in salivary gland acinar cells. Annu Rev Physiol. 2005;67:445-469.
45. Verkman AS, Matthay MA, Song Y. Aquaporin water channels and lung physiology. Am J Physiol Lung Cell Mol Physiol. 2000;278(5):L867-L879.